EUVIMEDEUVIMED entdecken
Crossref

Firm misled investors on Alzheimer’s drug, SEC charges

Charles Piller

Science · 2024

DOI: 10.1126/science.adt5694 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, 2024. Verfasst von Charles Piller. Hauptthemen laut MEDLINE: Alzheimer Disease, Drug Industry, Spiro Compounds, Scientific Misconduct. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Agency fines Cassava Sciences $40 million for touting flawed research on simufilam

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseDrug IndustrySpiro CompoundsScientific MisconductHumansInvestmentsUnited States

Substanzen

SimufilamSpiro Compounds

Zitieren

APA

Piller, C. (2024). Firm misled investors on Alzheimer’s drug, SEC charges. Science. https://doi.org/10.1126/science.adt5694

Vancouver

Piller C. Firm misled investors on Alzheimer’s drug, SEC charges. Science. 2024. doi:10.1126/science.adt5694

BibTeX
@article{Piller2024,
  author = {Piller, Charles},
  title = {Firm misled investors on Alzheimer’s drug, SEC charges},
  journal = {Science},
  year = {2024},
  doi = {10.1126/science.adt5694}
}
Kostenlos starten →